Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC)

Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab a monoclonal antibody against CTLA-4 in combination with ablative therapy in patients with hepatocellular carcinoma (HCC) Austin Duffy, Sid P Kerkar, David E Kleiner, Susanna Ulahannan, Metin Kurtoglu, Oxana Rusher, Suzanne Fioravanti, Melissa Walker, William D Figg, Kathryn Compton, Aradhana Venkatesan, Nadine Abi-Jaoudeh, Brad Wood, Tim F Greten